[이코노믹리뷰=황진중 기자] Dong-A ST announced on the 24th that it held the 8th regular shareholders’ meeting in the auditorium on the 7th floor of its headquarters in Yongdu-dong, Dongdaemun-gu, attended by shareholders and company management. At the board of directors held after the general shareholders’ meeting, Chairman Um Dae-sik and President Han Jong-Hyun were each appointed as CEOs.
On this day, at the regular shareholders’ meeting, the 8th (Jan. 2020 ~ Dec. 31, 2020) financial statements (including the statement of appropriation of retained earnings (draft)) and consolidated financial statements were approved, the articles of incorporation were partially changed, directors were appointed, and outsiders who became members of the audit committee. A total of six agenda items were proposed, including the appointment of directors, the appointment of members of the audit committee, and approval of the compensation limit for directors, and all passed according to the original draft.
In the 8th business report, Dong-A ST reported that sales amounted to KRW 588.6 billion and operating profit of KRW 34.1 billion, respectively, decreased by 4.2% and 40.2% compared to the previous year, respectively, based on separate financial statements in 2020, and subsequently approved financial statements and consolidated financial statements. The decision was made on the assumption that a cash dividend of 1,000 won per share of common stocks and common stocks was assumed.
In accordance with the amendment of the Commercial Act and the enforcement of the Act on Electronic Registration of Stocks and Bonds (Electronic Securities Act), some changes in the articles of incorporation were also approved.
Dong-A ST Chairman Uhm Dae-sik was re-elected as the executive director, and Han Jong-Hyun was newly appointed. As outside directors and audit committee members, Hee-ju Choi, adviser of Yulchon law firm, and Professor Jae-sang Ryu of Ewha Womans University, have been re-elected. In particular, outside director Jae-sang Ryu was elected separately in accordance with the amendment of the Commercial Act that one of the members of the audit committee must be elected separately.
In order to enhance transparency in governance and shareholder value, Dong-A ST consists of a majority of the outside directors, the internal decision-making body, and separates the CEO and the chairman of the board, and the outside director serves as chairman. In addition, the Evaluation and Compensation Committee and the Audit Committee, which are committees within the board of directors, are all composed of outside directors, and the Outside Director Candidate Recommendation Committee consists of more than two-thirds of outside directors.
Dong-A ST Chairman Uhm Dae-sik, Chairman of the General Shareholders’ Meeting, said in a greeting, “Dong-A ST’s overall sales declined due to the COVID-19 pandemic last year, but in the specialty drug sector, sales exceeded the market growth rate. “In the R&D field, this year, we will focus on global development of the biosimilar DMB-3115 of Stellara, a psoriasis treatment, and we plan to develop new drugs and conduct preclinical trials of new pipelines.” .
Chairman Eom Dae-sik continued, “Dong-A ST is strengthening its differentiated competitiveness through strategic investments such as the construction of a new Songdo factory, quality culture innovation, and digital transformation to prepare for the Corona 19 environment and the 4th Industrial Revolution. In addition to management activities, through the Social Value Committee launched last year, we will contribute to customers, local communities and stakeholders, and practice ESG-centered sustainability management.”